针对性治疗在的治疗
1Pediatric Neurology Department, CRMR épilepsies rares, AP-HP, Robert-Debré University Hospital, Paris, France; Institut hospitalo-universitaire Robert-Debré du cerveau de l'enfant, Paris, France; Inserm NeuroDiderot, université Paris Cité, Paris, France; Institut universitaire de France (IUF), Paris, France.
Revue neurologique
|April 12, 2025
概括
精准医学对罕见的儿科有希望,但将临床前发现转化为有效的治疗方法仍然是一个挑战. 需要进一步的临床验证来确认对耐药性的疗效.
科学领域:
- 神经学 神经学
- 遗传学 是一个遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 耐药性仍然是一个重大挑战,尽管抗发作药物的进展.
- 精准医学为罕见的儿科提供有针对性的治疗策略.
- 历史上的例子,如用于抗基因缺乏症的皮里多克辛和用于GLUT1缺乏症综合征的性饮食,说明了精确的方法.
研究的目的:
- 探索精准医学在治疗罕见儿科方面的潜力.
- 评估临床前发现的转化为药物耐药性的临床疗效.
- 讨论精确治疗的挑战和未来方向.
主要方法:
- 对中精准医学现有文献的综述.
- 对临床前证据和临床试验结果的分析.
- 成功和具有挑战性的精密处理的案例.
主要成果:
- 临床前研究已经确定了许多用于治疗的化合物.
- 临床试验,如用于结核性硬化综合体的everolimus,显示出有希望.
- 存在翻译性挑战,正如在KCNT1相关中用素所见的那样,具有异质的结果.
结论:
- 精准医学有可能成为罕见的机制驱动治疗方法.
- 临床试验验证对于在临床前发现的化合物至关重要.
- 这些精确方法在耐药性的整体疗效和疾病修饰作用需要进一步研究.
相关概念视频
Antiepileptic Drugs: Glutamate Antagonists
250
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
250
Antiepileptic Drugs: GABAergic Pathway Potentiators
261
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
261
Arteries of the Lower Limbs
167
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
167
Antiepileptic Drugs: Sodium Channel Blockers
269
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
269
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
188
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
188


